Encysive Pharmaceuticals Reports Third Quarter 2007 Financial Results
02 nov. 2007 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 2, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced financial results for the third quarter ended September 30, 2007.
"We made excellent progress in...
Encysive Pharmaceuticals to Present At the Acumen BioFin Rodman and Renshaw Healthcare Conference
30 oct. 2007 08h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that George Cole, Encysive's President and Chief Executive Officer, will present at the 9th Annual...
Encysive Pharmaceuticals Announces Long-Term Study of Sitaxsentan Presented At Chest Meeting
24 oct. 2007 16h01 HE
|
Encysive Pharmaceuticals Inc.
CHICAGO, Oct. 24, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that data from a long-term study with sitaxsentan sodium 100 mg tablets (THELIN(tm)) in patients...
Encysive Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2007 Results
16 oct. 2007 13h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 16, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will hold an investor conference call on Friday, November 2, 2007 at 8:00 a.m. ET to discuss its third quarter...
Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in France
11 oct. 2007 02h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 11, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in France for the...
Encysive Pharmaceuticals to Conduct Phase III Study With Thelin (Sitaxsentan Sodium) in Pulmonary Arterial Hypertension
24 sept. 2007 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 24, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company will move forward with plans to conduct an additional Phase III study...
Encysive Pharmaceuticals Refinances Argatroban Royalty Notes
21 sept. 2007 16h01 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 21, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its special purpose subsidiary, Argatroban Royalty Sub LLC ("Royalty Sub"), has refinanced...
Encysive Pharmaceuticals Announces Dismissal of Class Action Lawsuit
19 sept. 2007 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 19, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the United States District Court for the Southern District of Texas has dismissed, with...
Encysive Pharmaceuticals Announces Launch of THELIN (sitaxentan sodium) in Spain
13 sept. 2007 02h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 13, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (Sitaxentan sodium(2)) 100 mg tablets in Spain for the...
Encysive Pharmaceuticals Announces Presentation/Webcast At UBS Global Life Sciences Conference
06 sept. 2007 16h05 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that it will participate in the 2007 UBS Global Life Sciences Conference, being held at the Grand...